Free Newsletter
Cervical cancer vaccine bound for clinic; Businesses warned to prepare for vax campaigns;
Vaccine Research
VGX Pharmaceuticals says that the FDA has accepted its IND for an experimental DNA vaccine for cervical cancer. VGX-3100 will go into Phase I in the third quarter. Story
Researchers at the University of Pennsylvania School of Medicine have developed a new technique that tricks the human immune system to respond against multiple strains of bird flu. Release
Sinovac Biotech has begun to recruit patients for a mid-stage study of its bird flu vaccine. Report
Genetically engineered yeast has produced an anti-tumor response in mice. Story
Monash University scientists have started clinical trials to find a successful vaccine against footrot in sheep. Report
Vaccine market
Experts are warning companies in the U.S. to start preparing now for any upcoming flu vaccination programs. Release
WellPoint, one of the largest insurers in the U.S., says that it will reimburse for the new rotavirus vaccine Rotarix. Report
Physicians in the U.K. are being warned of a shortage of vaccines for children. Story
Comments
Post new comment
Paid Research Reports
- The Top 10 Biosimilar Players: Positioning, performance and SWOT analyses
- New Approaches to Pharma R&D: Evolving strategies to rejuvenate R&D efficiency
- Stakeholder Opinions: Vaccine antigen delivery technologies - Molecular systems to open new markets
- The Top 10 Contract Research Organizations
- Stakeholder Opinions: Vaccine administration technologies - Beyond needles
- Future Pharmaceutical Industry Trends: Long-term opportunities tempered by short-term challenges





Click here to get the FierceVaccines email newsletter for FREE!
Be the first to comment